Option Care Health, Inc. (OPCH)
- Previous Close
29.03 - Open
28.93 - Bid 24.87 x 100
- Ask 33.29 x 100
- Day's Range
28.70 - 29.02 - 52 Week Range
26.17 - 35.74 - Volume
192,737 - Avg. Volume
1,302,845 - Market Cap (intraday)
4.993B - Beta (5Y Monthly) 1.32
- PE Ratio (TTM)
18.77 - EPS (TTM)
1.53 - Earnings Date Jul 25, 2024 - Jul 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
39.57
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
www.optioncarehealth.com7,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: OPCH
Performance Overview: OPCH
Trailing total returns as of 5/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OPCH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OPCH
Valuation Measures
Market Cap
5.05B
Enterprise Value
6.00B
Trailing P/E
18.97
Forward P/E
25.25
PEG Ratio (5yr expected)
2.52
Price/Sales (ttm)
1.17
Price/Book (mrq)
3.53
Enterprise Value/Revenue
1.35
Enterprise Value/EBITDA
12.64
Financial Highlights
Profitability and Income Statement
Profit Margin
6.15%
Return on Assets (ttm)
6.21%
Return on Equity (ttm)
19.62%
Revenue (ttm)
4.43B
Net Income Avi to Common (ttm)
272.67M
Diluted EPS (ttm)
1.53
Balance Sheet and Cash Flow
Total Cash (mrq)
229.93M
Total Debt/Equity (mrq)
81.92%
Levered Free Cash Flow (ttm)
65.5M
Research Analysis: OPCH
Company Insights: OPCH
OPCH does not have Company Insights